HOLLYWOOD, Calif., May 30, 2013 /PRNewswire/ -- Medbox, Inc. (OTC Markets: MDBX) (www.medboxinc.com), a leader in providing consulting services and patented systems to the medical and retail industries, announced today that Vaporfection, their wholly owned subsidiary, is on pace to post record sales in 2013 - surpassing last year's historic $1.4 million sales performance.
Vaporfection has a line of vaporizing products that are considered the highest quality in the world, with industry-leading features and user benefits, including:
"We are pleased with Vaporfection's sales to date, and we look forward to increasing sales exponentially when we gear up our new marketing campaign," stated Dr. Bruce Bedrick , CEO of Medbox, Inc. "As the medical marijuana industry continues to grow, patients are seeking better and healthier delivery systems. Vaporfection provides state-of-the-art technology in affordable and mass-marketable delivery products."
For more information on Medbox, visit: www.thedispensingsolution.com
For more information on Vaporfection, visit: www.vaporfection.com
About Medbox, Inc:
Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Medbox has offices throughout the world, including New York, Arizona, Connecticut, Massachusetts, Tokyo, London and Toronto, and has their corporate headquarters in Los Angeles.
Medbox provides their patented systems, software and consulting services to pharmacies, dispensaries, urgent care centers, drug rehab clinics, hospitals, prison systems, hospice facilities, and medical groups worldwide.
Medbox, Inc. is a publicly traded company, and is quoted on the OTC Markets, ticker symbol MDBX.
For more information on Medbox, please contact the Medbox Investor Relations Department at (800) 762-1452 or go online to www.medboxinc.com.
|SOURCE Medbox, Inc.|
Copyright©2012 PR Newswire.
All rights reserved